Ebos Group Limited (NZX: EBO), a dual-listed animal and healthcare company, has successfully secured $217 million through a fully underwritten placement of new shares to institutional investors. This forms part of its broader $270 million equity raising plan, which also includes a non-underwritten retail offer of up to $54 million for eligible shareholders. The capital raise supports Ebos’ strategic acquisition of SVS Veterinary Supplies, a pet medicine firm, for $115 million. The company noted that both new and existing investors participated in the placement. This acquisition and funding initiative reflects Ebos’ continued growth in the veterinary and animal health sector. The retail component of the offer is expected to open shortly, providing existing shareholders the opportunity to invest further. The equity raise positions Ebos to strengthen its presence in the rapidly expanding animal healthcare market.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
May 19, 2025
May 19, 2025
May 16, 2025
May 16, 2025
May 15, 2025
May 15, 2025
May 14, 2025
May 14, 2025
May 13, 2025
May 13, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva New Zealand Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
